Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

California Governor Signs Bill Making Autism Service Providers Mandated Reporters


https://www.prweb.com/

Center for Autism and Related Disorders, LLC (CARD) Logo

Children with autism may not always be able to advocate for themselves, so it’s imperative that all individuals who provide services to them are trained to recognize and report suspected abuse.

California Governor Gavin Newsom has signed Assembly Bill 189, a bill authored by Assembly Member Sydney Kamlager-Dove (D – Los Angeles) and co-sponsored by the Center for Autism and Related Disorders (CARD). The bill, which adds autism service providers to the state’s list of individuals who are mandated reporters, received overwhelming support from both the California Assembly and Senate.

By making qualified autism service providers, professionals and paraprofessionals mandated reporters, AB 189 makes it a crime for these individuals not to report suspected child abuse or neglect.

“Children with autism may not always be able to advocate for themselves, so it’s imperative that all individuals who provide services to them are trained to recognize and report suspected abuse,” said Assembly Member Kamlager-Dove.

“We are so thankful for Assembly Member Kamlager-Dove’s dedication to California’s autism community,” said Doreen Granpeesheh, Ph.D., BCBA-D, chief executive officer and founder of CARD. “Children with autism are at a higher risk for abuse, so it’s critical for those who provide services to these children to be trained to recognize and report abuse.”

California is home to more autism treatment providers than any other state, and the field of autism treatment continues to grow to meet the needs of individuals diagnosed with autism spectrum disorder. The Child Abuse and Neglect Reporting Act (CANRA) will now explicitly require autism treatment providers and their clinical employees to report suspected incidents of abuse or neglect.

According to Assembly Member Kamlager-Dove, “Mandated reporter laws are in place to prevent children, along with at-risk individuals, from being abused and to end abuse or neglect at the earliest possible stage. Adding qualified autism service providers to the list of individuals who are mandated reporters under CANRA will help to protect children on the autism spectrum.”

Autism treatment providers will be required to provide their clinical employees with a statement informing them of their mandated reporter status and explaining their obligations to report suspected child abuse and neglect. To make a report, a mandated reporter must immediately contact the appropriate law enforcement agency. The new law takes effect January 1, 2020.

About Center for Autism and Related Disorders (CARD)

CARD treats individuals of all ages who are diagnosed with autism spectrum disorder (ASD) at treatment centers around the globe. CARD was founded in 1990 by leading autism expert and clinical psychologist Doreen Granpeesheh, PhD, BCBA-D. CARD treats individuals with ASD using the principles of applied behavior analysis (ABA), which is empirically proven to be the most effective method for treating individuals with ASD and recommended by the American Academy of Pediatrics and the US Surgeon General. For more information, visit http://www.centerforautism.com or call (855) 345-2273.

Share article on social media or email:

A2LA Accredits North Coast Analytical Laboratories and North Coast Testing Laboratories to ISO/IEC 17025


News Image

“Our accreditation by A2LA is a testament to our ability to meet the most rigorous quality management standards in analytical testing of hemp products, and a vote of confidence in our team’s ability to perform at the highest levels.” – Nick Szabo, Laboratory Director, North Coast Analytical.

A2LA is pleased to announce the accreditation of both North Coast Analytical Laboratories and North Coast Testing Laboratories to ISO/IEC 17025:2017 for cannabis testing. Both of these laboratories are located in Streetsboro, Ohio and are A2LA’s first accredited cannabis testing laboratories in the state. North Coast Testing provides testing to service the medical marijuana industry and North Coast Analytical provides testing to service the hemp industry.

“We are extremely proud of the work of our entire team in rapidly developing and implementing a comprehensive quality management program that can give all participants in the Ohio Medical Marijuana Control Program confidence in the quality and safety of products tested in our laboratory,” said Carolyn Friedrich, Ph.D., Scientific Director at North Coast Testing.

“Our accreditation by A2LA is a testament to our ability to meet the most rigorous quality management standards in analytical testing of hemp products, and a vote of confidence in our team’s ability to perform at the highest levels,” said Nick Szabo, Laboratory Director at North Coast Analytical. “A2LA went above and beyond at every step, and we greatly appreciate their efforts.”

“We congratulate North Coast Analytical Laboratory and North Coast Testing Laboratory for being the first accredited cannabis testing laboratories in the state of Ohio”, said Chris Gunning, Accreditation Services General Manager at A2LA. Their commitment to excellence was evident in the facilities that they have constructed, the staff they have assembled, and the quality system they have implemented. This dedication to quality results will be an asset to customers in Ohio.”

Achieving ISO/IEC 17025 accreditation by A2LA is the pinnacle in third-party laboratory accreditation, as it confirms that laboratories have management, quality, and technical systems in place to ensure accurate and reliable analyses, as well as proper administrative processes to ensure that all aspects related to the sample, the analysis, and the reporting are standardized, measured, and monitored.

About A2LA

A2LA is a non-profit, non-governmental, third-party accreditation body, offering internationally-recognized accreditation services and training to testing and calibration laboratories, sampling organizations, inspection bodies, proficiency testing providers, reference material producers and product certifiers. For more information about A2LA, please visit http://www.A2LA.org.

About North Coast Testing Laboratories, LLC

North Coast Testing Laboratories, LLC is a full-service ISO 17025-accredited medical marijuana testing laboratory focused on providing precise analytical test results and guaranteed turnaround times. Made up of a team of industry-leading scientists possessing an in-depth knowledge of cannabis and cannabis infused products, North Coast Testing has combined cutting-edge technologies, principled laboratory practices and unparalleled customer service to bring the medical marijuana testing industry the most reliable analytical results possible.

About North Coast Analytical Laboratories, LLC

North Coast Analytical Laboratories, LLC is a full-service ISO 17025-accredited cannabis testing laboratory focused on providing precise analytical test results and guaranteed turnaround times. Made up of a team of industry-leading scientists possessing an in-depth knowledge of cannabis and cannabis infused products, North Coast Analytical has combined cutting-edge technologies, principled laboratory practices and unparalleled customer service to bring the hemp and CBD-products industry the most reliable analytical results possible.

Share article on social media or email:

Hospital Billing Practices are Under a Microscope and Providers are Responding to the Public and Political Scrutiny


https://www.prweb.com/

Healthcare providers are learning that aggressive patient collection tactics damage their brands and alienate healthcare consumers

With patients on the hook for so much more of the cost, a provider’s reputation matters. Suing patients to collect from them and other aggressive collection tactics have no place in a business-building strategy. – Kevin Fleming, CEO, Loyale Healthcare

In recent months, U.S. news media have been paying closer-than-usual attention to the ways hospitals bill and collect from patients. The issues range from surprise bills to overzealous collection methods that have gone so far as to seize paychecks and tax refunds – even claim homes. This scrutiny has fueled mounting public anger, prompting U.S. lawmakers to launch an investigation into provider billing practices. The focus of this anger has also expanded to include the private equity owners of some U.S. healthcare companies.

These forms of behavior turn the provider-patient relationship on its head – from care giver to financial adversary. Even more damaging, aggressive collection tactics frighten prospective patients. Concerned and uncertain about what they will owe and how they will pay for the care they need; many decide to skip care entirely. Research results vary on this topic, but the number of people who avoid or delay care because of concerns about their ability to afford it range from fifty percent to sixty-four percent.

There are two sides to this story. Healthcare providers are in a tough spot, too. They are expected to deliver exceptional clinical care and required to meet high regulatory standards. At the same time, they are struggling to collect from financially burdened patients with systems that were developed decades ago to collect from insurance companies. The solution to this problem, it seems, depends on providers’ willingness to abandon adversarial tactics and embrace a more personal, compassionate approach.

Healthcare in a Consumer-Driven Market: Brand Matters

You may have heard the expression, “there’s no such thing as bad publicity”, but ask any executive in an industry that relies on the good will of the buying public and they’ll tell you otherwise. Trusted companies like Disney, Apple, Nike and others spend untold millions in time and money to maintain, protect and grow brands that cultivate long-term consumer relationships. How these companies are perceived in the marketplace is fundamental to their continued success.

Healthcare now finds itself in a similar spot. When the insurance companies did most of the paying, a hospital’s brand was primarily clinical in nature and the financial experience didn’t matter that much. Patients chose the providers that were in their plan’s network, the provider delivered treatment and the payer paid. But now that patients are on the hook for so much more of the cost, they’re behaving differently. Suddenly, a provider’s reputation matters. In such an environment, suing patients to collect from them and other aggressive collection tactics have no place in a business building strategy.

Instead, more and more providers are developing consumer-centric, retail-like experiences. Recognizing that patient preference will be the principle driver of volume and revenue, they’re reimagining the patient experience from new, much larger perspectives. HCA Healthcare is one example. One of the largest and most successful healthcare brands in America, HCA is focused on constantly improving the patient’s financial journey.

Loyale Healthcare has partnered with over 12,000 healthcare facility customers representing in excess of $50 Billion in annual net patient revenue and forty million patient encounters. With a focus on delivering end-to-end functionality, our solution supports six key patient financial elements, all of which contribute to improved patient financial experiences and provider brand value:

1.    Price transparency – One of the biggest problems facing the healthcare industry’s transition into a consumer-first operating model is its pervasive inability to provide patients with reliable upfront estimates for care. In every other purchase decision we consumers make, price is one of the most important considerations. Until now, healthcare has been exempt, but those days are numbered. The government and powerful new competitors like Haven Healthcare, CVS Health and others will see to that.

2.    Payment planning – When a patient knows early what their care is likely to cost, and how much their out-of-pocket will be, they can plan for the expense. With Loyale’s Affordability Workbench™, patients have access to multiple payment options that include discounts for early or prompt payment; short-term, no interest payment schedules; or longer-term payment plans through a third-party lender. Serving themselves online, or working with hospital staff, patients can get the care they need while focusing on payments they can afford, not just worrying about what they’ll owe.

3.    Personalized digital & human communications – Patients are often slow to react to traditional hospital billing communications. Whether sent by mail, email or online over the hospital’s patient portal, form letters do nothing to engage patients or provide the clarity they need to understand and act on their financial obligations. Loyale’s personalized digital communication platform, on the other hand, automatically segments patient populations. By integrating with patient preferences, we then deliver the right messages at the right frequency over the right channel – email, text, chat or by initiating a human conversation.

4.    One Bed. One Bill – Ask most patients and they’ll tell you… they’re confused, frustrated and angry about their healthcare bills. “It was one stay in one bed for one thing. Why did I get eleven bills?” With the Loyale platform, Providers can now consolidate bills into one, comprehensive virtual “bill” presentation that patients can understand and act on. Loyale’s underlying technology takes care of making sure the payments get where they need to go.

5.    Seamless, holistic experiences – Healthcare has long separated patient experiences into two different categories; the clinical and the administrative/financial. But patients will tell you that they have just one care experience, and that experience includes every interaction the patient has with the provider, every time. That’s why Loyale integrates with the Provider’s clinical portal. Additionally, its provider-facing portal gives hospital staff and call centers the patient’s account view for easy problem solving.

6.    Provider facing tools to improve productivity and increase revenues – Beginning well before treatment, the Loyale patient financial engagement platform collects and aggregates data to qualify patients. Then the system automatically generates intelligent workflows that reduce staff work and improve the probability of patient payment. Additionally, the tool’s highly configurable reporting and dashboard functionality is now giving health systems the “best visibility into patient-pay revenue cycle they have ever had”. This invaluable business intelligence is making it possible for leadership to find and promote best practices and tackle underperforming practices.

By delivering patient-first financial experiences, healthcare providers across the country are finding that patients are eager to engage. This leads to dramatic increases in patient self-service, reduced costs for traditional paper billing and collections and higher patient-pay revenue. Best of all, it responds to patient expectations for transparency, clarity and inclusion. By partnering with them in the financial dimension of care, healthcare can now provide patients and their communities with healthcare financial experiences they can understand and control.

Kevin Fleming is the CEO of Loyale Healthcare

About Loyale

Loyale Patient Financial Manager™ is a comprehensive patient financial engagement technology platform leveraging a suite of configurable solution components including predictive analytics, intelligent workflows, multiple patient financing vehicles, communications, payments, digital front doors and other key capabilities.

Loyale Healthcare is committed to a mission of turning patient responsibility into lasting loyalty for its healthcare provider customers. Based in Lafayette, California, Loyale and its leadership team bring 27 years of expertise delivering leading financial engagement solutions for complex business environments. Loyale currently serves approximately 12,000 healthcare providers across 48 states. Loyale recently announced an Enterprise level strategic partnership with Parallon including deployment of its industry leading technology to all HCA hospitals and Physician Groups.

ASGCT Presents Career Development Awards to Six Members


ASGCT’s Career Development Awards support independent transformative pilot studies in gene and cell therapy conducted by ASGCT members, particularly those ideas that would be challenging to fund with normal funding mechanisms.

The American Society of Gene and Cell Therapy (ASGCT) has selected six members to receive $50,000 Career Development Awards, a total distribution of $300,000. This group of awardees is ASGCT’s second class of Career Development Award recipients, a program in which ASGCT recognizes members who are transitioning toward independence in their careers.

ASGCT’s Career Development Awards support independent transformative pilot studies in gene and cell therapy conducted by ASGCT members, particularly those ideas that would be challenging to fund with normal funding mechanisms. The Society is also interested in helping applicants generate preliminary data to use in larger proposals (NIH K awards, first-submission R-level funding, etc.). The recipients were chosen by a selection committee made up of industry leaders identified by the ASGCT Board of Directors.

ASGCT’s six awardees are a diverse group from varied and wide-ranging specialties:

Mohommadsharif Tabebordbar, Ph.D.—postdoctoral associate, Broad Institute of MIT and Harvard

Developing liver-detargeted and muscle-tropic AAV capsid variants across species

Geoffrey L. Rogers, Ph.D.—postdoctoral scholar, University of Southern California

Improved strategies for site-specific gene insertion using non-homologous end joining

Daniel L. Kiss, Ph.D.—assistant professor, Houston Methodist Research Institute

Construction of circular RNAs to block miRNA-driven oncogenic transformation

Kshitiz Singh, M.B.B.S., M.M.S.T., Ph.D.—research fellow, Children’s Hospital of Philadelphia

Development of non-viral mechanisms of targeting lung epithelial cells for prenatal gene editing in a large animal model

Christopher Nelson, Ph.D.—assistant professor, University of Arkansas

Characterizing and overcoming the host response to genome editing therapy

Kalpana Parvathaneni, MS, Ph.D.— postdoctoral researcher, Center for Cellular Immunotherapies, University of Pennsylvania

Engineered CAR-T Cells to Overcome Alloimmunity in Transplant Rejection

ASGCT is honored to have received such strong interest from its membership and congratulates this strongly-qualified group of awardees. The 2020 Career Development Awards program will begin accepting applications shortly after the 23nd ASGCT Annual Meeting, May 12-15, held at the Hynes Convention Center in Boston.

About ASGCT

The American Society of Gene & Cell Therapy is the primary professional membership organization for scientists, physicians, patient advocates, and other professionals with interest in gene and cell therapy. Our members work in a wide range of settings including universities, hospitals, government agencies, foundations, biotechnology and pharmaceutical companies. ASGCT advances knowledge, awareness, and education leading to the discovery and clinical application of gene and cell therapies to alleviate human disease to benefit patients and society.

Share article on social media or email:

Worcester Polytechnic Institute Researcher Creating Safer, More Accurate Way to Detect Prostate Cancer


Haichong "Kai" Zhang

Haichong “Kai” Zhang is developing an MRI-guided robotics system to detect and monitor prostate cancer.

A biomedical engineer at Worcester Polytechnic Institute (WPI) is creating a new medical robot that uses minimally invasive technologies to safely and accurately detect and monitor prostate cancer, the second-leading cause of cancer-related deaths among American men.

Haichong (Kai) Zhang, assistant professor in biomedical engineering and robotics engineering, received a five-year $1,869,423 Director’s Early Independence Award from the National Institutes of Health (NIH) for his ongoing work to create a robotic system that will detect and analyze three different indicators of prostate cancer: a 3D image of any mass; high levels of a protein produced by cancer cells; and tissue with low-oxygen levels caused by cancer growth.

By simultaneously focusing on these different but complementary signs of prostate cancer, Zhang expects his system will be more accurate than current tests like ultrasounds and biopsies unguided by MRIs. His work also may eliminate the need for radioactive contrast dye, which is used in traditional scans and poses other health risks.

“One fifth of men will be diagnosed to have prostate cancer in their lifetime and the recurrence of it is very high,” said Zhang, who is the PI on the research project, “Multiparametric Photoacoustic Imaging-Based Identification of Aggressive Prostate Cancer” (DP5 OD028162).

“Right now,” he said, “the best methods for detecting prostate cancer early are not nearly as accurate as we need them to be, and they are not risk-free. My goal is to create a minimally invasive, easily accessible, and cost-effective way to better detect this cancer.”

According to 2016 cancer data from the NIH, prostate cancer was the most commonly diagnosed non-cutaneous cancer and nearly 200,000 new cases were diagnosed in the U.S. that year. Diagnosis of prostate cancer generally involves a blood test to check for prostate-specific antigens (PSA) that may indicate cancer, a manual rectal examination, biopsies, and ultrasounds. Biopsy samples taken randomly often lead to the underestimation of a high-risk prostate cancer, false negative diagnoses, and the need for repeat biopsies. The NIH reported that the grade or stage of prostate cancer was only accurately determined in 37% of biopsied cases.

Zhang and Gregory Fischer, professor of robotics engineering and a widely known pioneer in the emerging field of MRI-guided robotic surgery, will create a surgical imaging robot that works within an MRI machine to insert an imaging probe into the patient’s rectum, adjacent to the prostate. Once an image is captured, the probe will be robotically manipulated so it can capture other images from slightly different angles, ultimately compiling a 3D image of the prostate and any tumor that is present. This technology will show the tumor in earlier stages than an ultrasound image, which generally shows the structure of the prostate but not a tumor’s location, and often fails to detect early stage tumors. The robotic system also is being designed to conduct guided-needle biopsies. By using the photoacoustic system, the robotic arm can pinpoint the tumor and specifically target it.

Zhang’s robotic device will use photoacoustic imaging, which is the combination of optical imaging and ultrasound, pulsing light into tissue and receiving acoustic waves in return. The acoustic signal provides information about the health of the tissue, which a traditional ultrasound does not. Different kinds of tissue emit different kinds of acoustic waves so the system will be able to differentiate between healthy, well-oxygenated tissue and tissue that is hypoxic, or depleted of oxygen. Cancer cells reduce the transportation of oxygen and nutrients in surrounding blood vessels.

“Three-D images, PSMA detection and hypoxia detection are all complimentary,” said Zhang. “They all give us different clues, different approaches to detecting cancer at a much higher sensitivity. That means we should be able to detect prostate cancer earlier when it’s much more treatable.”

Fischer said he is excited to work with Zhang to create the next-generation of his MRI-guided robot for prostate cancer detection and treatment. “With Zhang’s technology, we’ll have a greater ability to identify a mass and to directly target it with a biopsy needle. That’s key.”

Zhang also is working with researchers at Johns Hopkins University to develop a non-radioactive contrast agent that can be used during the photoacoustic imaging to target PSMA, a specific protein expressed in prostate cancer that may indicate the presence of an aggressive form of the disease. This may eliminate the need for current contrast agents, which are radioactive and can pose additional health risks.

The NIH Director’s Early Independence Award, established in 2010, is part of the organization’s High-Risk, High-Reward Research Program, which supports what the NIH describes as “exceptionally creative scientists pursuing highly innovative research with the potential for broad impact.” The award provides an opportunity for junior scientists who have recently received their doctoral degrees or completed medical residency to skip traditional post-doctoral training and move immediately into independent research positions. Thirteen such awards will be made for 2019.

Zhang earned his PhD in computer science at Johns Hopkins. While there, he received a nearly $200,000 grant from the Department of Defense and the Congressionally Directed Medical Research Programs to work on imaging research related to his current project.

About Worcester Polytechnic Institute

WPI, a global leader in project-based learning, is a distinctive, top-tier technological university founded in 1865 on the principle that students learn most effectively by applying the theory learned in the classroom to the practice of solving real-world problems. Recognized by the National Academy of Engineering with the 2016 Bernard M. Gordon Prize for Innovation in Engineering and Technology Education, WPI’s pioneering project-based curriculum engages undergraduates in solving important scientific, technological, and societal problems throughout their education and at more than 50 project centers around the world. WPI offers more than 50 bachelor’s, master’s, and doctoral degree programs across 14 academic departments in science, engineering, technology, business, the social sciences, and the humanities and arts. Its faculty and students pursue groundbreaking research to meet ongoing challenges in health and biotechnology; robotics and the internet of things; advanced materials and manufacturing; cyber, data, and security systems; learning science; and more. http://www.wpi.edu

Media contact:

Alison Duffy, Director of Strategic Communications

Worcester Polytechnic Institute

Worcester, Massachusetts

508-831-6656, amduffy@wpi.edu

HMP Expands Partnership with the International Certification & Reciprocity Consortium


News Image

In the midst of an unprecedented addiction crisis, this partnership provides thousands of IC&RC-credentialed professionals access to critical, evidence-based education presented by the field’s leading experts.

HMP, a leading healthcare event and education company, today announced an expanded partnership with the International Certification & Reciprocity Consortium (IC&RC), the leader in the credentialing of prevention, substance use treatment, and recovery professionals. As part of the arrangement, the National Conference on Addiction Disorders (NCAD) East and West, part of HMP’s Psychiatry & Behavioral Health Learning Network, are official conferences of IC&RC. The two organizations will work jointly on educational and marketing initiatives around the two meetings.

Organized in 1981, IC&RC is the largest credentialing organization in the world and represents more than 50,000 professionals in the U.S. and globally. IC&RC promotes public protection by offering internationally recognized credentials and examinations to professionals.

For more than ten years, the NCAD brand has focused on delivering exceptional face-to-face education to address addiction disorders. In 2019, the meeting expanded into East and West offerings. Through comprehensive clinical agendas, the meetings allow attendees to hear new research and share cross-discipline insight on forward-thinking topics such as medication-assisted treatment, benzodiazepine use, and advances in treatment technologies. Nearly 1,000 professionals participated in NCAD East in Baltimore, Maryland, in August, and 400 are expected to participate in the inaugural NCAD West, taking place October 24–26 in Denver, Colorado.

“We are honored to be strengthening our collaboration with IC&RC,” said Doug Edwards, Director, HMP Psychiatry & Behavioral Health Learning Network. “In the midst of an unprecedented addiction crisis, this partnership provides thousands of IC&RC-credentialed professionals access to critical, evidence-based education presented by the field’s leading experts in order to continue to advance the profession and quality care for those challenged by addiction.”

“The IC&RC looks forward to this enhanced strategic partnership with HMP,” said Crystal Smalldon, RSSW, CCAC, CIAC, IC&RC President and Executive Director. “Together, IC&RC and HMP are committed to advancing the profession. HMP produces the leading national conferences in this field, and this agreement provides a unique opportunity to provide our community of professionals the highest quality education to continually improve and refine patient care and recovery services. This represents real impact.”

To learn more about NCAD East and West, visit theaddictionconference.com.

For media inquiries, contact Kelly McCurdy at pr@hmpglobal.com.

About HMP

HMP is the force behind Healthcare Made Practical—and is a multichannel leader in healthcare events and education, with a mission to improve patient care. The company produces accredited medical education events and clinically relevant, evidence-based content for the global healthcare community across a range of therapeutic areas. Its brands include Consultant360, the year-round, award-winning platform relied upon by primary care providers and other specialists; Psych Congress, the largest independent mental health meeting in the U.S.; Rx Drug Abuse & Heroin Summit, the largest annual gathering on the opioid crisis; EMS World Expo, North America’s largest EMT and paramedic event; and the Symposium on Advanced Wound Care (SAWC), the largest wound care meeting in the world. For more information, visit hmpglobal.com.

About the International Certification & Reciprocity Consortium (IC&RC)

IC&RC promotes public protection by setting standards and developing examinations for the credentialing and licensing of prevention, substance use treatment, and recovery professionals. Organized in 1981, IC&RC has 73 member certification and licensing boards in 48 U.S. states and territories, four Native American regions, all branches of the U.S. military, and 11 international regions. Representing more than 50,000 professionals, IC&RC is the global leader in the credentialing of prevention, substance use treatment, and recovery professionals. To learn more about IC&RC, visit internationalcredentialing.org.

Share article on social media or email:

Virtue Technologies Announces Investment by Claritas Capital


News Image

“We are excited and encouraged in the market’s response to Virtue Technologies,” says Gibran Ameer, “moreover, we are very pleased in the confidence that Claritas Capital has placed in us.”

Virtue Technologies, a leading provider of post-acute healthcare technology solutions, announced today that Claritas Capital, a Nashville-based private equity firm, has invested in the company. Created out of a joint venture between TwelveStone Health Partners and VirtueRN, the new company addresses the fragmented market that exists among organizations who communicate orders to service providers and the patients who need them in post-acute care environments. The solutions streamline workflow processes and increase the level of communication that occurs across the continuum of post-acute care.

“The delivery of post-acute care can often be quite challenging,” says Gibran Ameer, Chief Executive Officer of Virtue Technologies. “Technology is a means to un-complicate and simplify business processes – our solutions do just that. This results in a positive impact to operational efficiencies, costs, revenue cycle and ultimately a better patient experience.”

“Virtue Technologies is unique as they have successfully developed innovative technology solutions based on the founders’ deep understanding of the complexities associated with providing care and serving patients in the post-acute care market,” said Theresa Sexton, Partner, Claritas Capital. “We are excited to support the Virtue Technologies team as they provide solutions which promote service excellence, increase productivity, and fills the gaps in an otherwise fragmented marketplace.”

“We are excited and encouraged in the market’s response to Virtue Technologies,” says Gibran Ameer, “moreover, we are very pleased in the confidence that Claritas Capital has placed in us.”

About Virtue Technologies

Virtue Technologies is a provider of cloud-based software committed to solving the challenges of the highly fragmented pharmacy market. The solutions strive to drive out cost and improve a pharmacy’s revenue cycle by improving staff efficiency, removing waste, increasing patient satisfaction, and providing unparalleled visibility to pharmacy operations. In an environment of shrinking reimbursements, growing audit risk, and persistent demand from patients and caregivers, Virtue Technologies provides the solutions the market demands.

About Claritas Capital

Nashville-based Claritas Capital has been making health care investments since its founding in 2002. The Principals’ experience covers three decades of investing in the health care industry. Claritas Capital provides flexible capital solutions to health care, technology, and business services companies, and real estate projects. The firm has made equity investments in over 50 companies that have collectively raised over $6 billion of financing.

Jason Jacobs, COO

Virtue Technologies

jason.jacobs@virtuescript.com

(803) 932-6450

Kali Huff, Investor Relations

Claritas Capital

khuff@claritascapital.com

(615) 690-7183

Share article on social media or email:

A Fertility Doctor’s Fight for Motherhood


News Image

I have the unique opportunity of being both a fertility doctor and patient. I tell the story from both sides of the exam table. – Dorette Noorhasan, MD, author of Miracle Baby

Dr. Dorette Noorhasan offers a unique perspective on the fertility struggle women face in her book, Miracle Baby: A Fertility Doctor’s Fight for Motherhood (Brown Books Publishing Group), which releases today, October 22, 2019. As a board-certified OB-GYN and fertility specialist, Noorhasan writes to educate, encourage, advise and support people who want to bring a new life into the world. Her own journey to motherhood was filled with many difficulties and unexpected turns that led to a role reversal.

“I have the unique opportunity of being both a fertility doctor and patient,” Noorhasan said. “I tell the story from both sides of the exam table.”

Miracle Baby is Noorhasan’s emotional and inspirational memoir, revealing her experiences of tragedy as a child, her journey from South America to the United States of America with her family, and the personal hardships she endured before her son was born via surrogacy. In this narrative, she opens wide the discussion of fertility complications from which one in eight women suffers. Her story offers comfort to women in similar situations and displays the power of hope, courage and determination in producing the miraculous.

Dr. Noorhasan has also developed The Fertility Manual: Reproductive Options for Your Family, which will be released in November 2019. It will serve as an accompanying guide for her readers to explore and understand fertility possibilities they may have never considered.

“The role of The Fertility Manual is to provide basic fertility terminology,” Noorhasan said. “The book will educate readers who might be seeking fertility treatment with the knowledge they need to ask their doctors the right questions as they pursue parenthood.”

For more information about the author and her books, please visit http://www.noorhasan.com.

Share article on social media or email:

Dedicated Senior Medical Centers Offer Affordable VIP Care


https://www.prweb.com/

Dedicated Logo

We’ve been transforming care for at-risk seniors for more than 30 years, because our doctors earn more trust.

ChenMed, a nationally recognized physician-led primary care provider serving seniors in Florida and seven more states through more than 60 locations, today announced grand opening for the third of three Dedicated Senior Medical Centers in Palm Beach County. The new Dedicated centers — located in underserved Delray Beach, Greenacres and Riviera Beach neighborhoods – honor seniors with affordable VIP care that delivers better health.

In stark contrast to traditional fee-for-service medical practices across America, where it’s frequently hard for patients to schedule timely appointments with their primary care physicians, Dedicated doctors make it easy for patients to stay connected with the doctor who knows them best. They provide high-touch personalized primary care, giving patients their personal cell phone numbers for timely replies to texts and/or calls. Plus, they welcome walk-in appointments whenever needed by their Medicare-eligible patients.

“Our expansion into Palm Beach County means more healthy days for thousands of deserving seniors – especially those living with multiple and major chronic health challenges,” says Christopher Chen, M.D., CEO of ChenMed. “We’ve been transforming care for at-risk seniors for more than 30 years, because our doctors earn more trust. They better detect and manage high-risk diseases. Plus, they reduce hospital admissions by investing substantively more time with every patient.”

Jason Barker, Regional Market President for 26 Chen and Dedicated Senior Medical Centers throughout Florida concurs, noting that “our primary care doctors serve an average of just 400 patients each. That’s less than one-fifth the national average of 2,300 patients per primary doctor, and it’s a real quality of care advantage for our seniors.”

The current and rapidly growing Dedicated Palm Beach County clinical team already includes:


ChenMed’s five-year investment in Palm Beach County is expected to exceed $60 million as the senior-focused practice provides intensive primary care for up to 8,000 seniors. Initially, the three Dedicated centers in Palm Beach County will employ about 60 full-time workers, including front desk, Medical Assistants, RN case managers, and physicians – the vast majority of whom will be hired locally.

The Dedicated Centers in Palm Beach County are located at:

  • Greenacres – 4998 10th Avenue North (corner of 10th and Haverhill)
  • Delray Beach – 5848 West Atlantic Avenue
  • Riviera Beach – 3002 Broadway Avenue


Ribbon cutting at Riviera Beach, Wednesday, October 23

  • When:         10:00 a.m. to 2:00 p.m.
  •                      10:30 to 10:45 a.m. VIP tour
  •                      10:45 to 11:15 a.m. official welcome and ribbon cutting
  • Who:            ChenMed founder James Chen, M.D., Ph.D.
  •                      ChenMed Chief Medical Officer Gordon Chen, M.D.; Riviera Beach
  •                      Councilwoman Dr. Julia Botel and Councilman Douglas A. Lawson
  •                      Dedicated doctors, diverse community leaders and 150 to 200 seniors


More time with patients means better outcomes

The Dedicated center concept is simple and vital to Medicare-eligible seniors, many of whom are living with major and multiple chronic health challenges. Dedicated primary care physicians average 10 times more face-to-face time with their patients than a typical physician does. Instead of the national average of just 20.3 minutes of direct time yearly with patients, Dedicated patients benefit from average time with doctor exceeding 200 minutes annually. The more doctors see their patients, the better they know them. And the better they know them, the better chance they have of helping them stay healthy by catching small issues before they turn into big ones.

Important personalized care benefits for Dedicated patients include:

  • Door-to-doctor transportation, if necessary.
  • Having his/her Dedicated primary care physician’s cell phone number for timely help.
  • Walk-in appointments.
  • Unlimited visits.
  • On-site cardiology, medication dispensing, imaging, labs, acupuncture, and more.
  • Healthy lifestyle classes.
  • Almost all costs of care paid by Medicare, Medicaid and Medicare Advantage insurance.


About ChenMed

For seniors most in need of care, high-quality health care often is beyond reach. ChenMed brings concierge-style medicine — and better health outcomes — to the neediest populations. ChenMed is a privately owned medical, management and technology company that operates more than 60 primary care medical practices for seniors in Florida, Georgia, Illinois, Kentucky, Louisiana, Ohio, Pennsylvania and Virginia. Its brands include Chen Senior Medical Center, Dedicated Senior Medical Center, and JenCare Senior Medical Center.

Results of its high-touch approach to primary care are impressive, as illustrated in the Modern Healthcare cover story (Oct. 20, 2018), which reports, “Indeed, ChenMed’s approach has resulted in 50 percent fewer hospital admissions compared with a standard primary-care practice, 28 percent lower per-member costs and significantly higher use of evidence-based medications.” Inspired by ChenMed chairman and founder James Chen, M.D., Ph.D., the company has been serving low-to-moderate-income seniors with multiple complex chronic conditions for over 30 years.

Share article on social media or email:

Pivot Point Consulting Continues to Invest in a Differentiated Experience and Advisory Services


News Image

Pivot Point Consulting invests in top notch healthcare IT leaders who bring decades of practical strategy and implementation experience to deliver value for both today’s and tomorrow’s opportunities.

Pivot Point Consulting, a Vaco Company, continues to invest in a differentiated experience for clients and consultants, as well as advisory services with the recent additions of Mauraan Schultz, Vice President, Delivery, and Joe Clemons, Director, Advisory Services.

Schultz started her career in pharmacy operations and moved on to work with firms including Ernst & Young, Accenture, McKesson and several dot coms. With 20+ years of healthcare IT experience in digital health and customer experience leading implementations and strategic projects, she will drive delivery excellence with clients and consultants.

“Pivot Point Consulting has a “customer first” mentality. With the rise of consumerism in healthcare, now, more than ever, healthcare organizations have an opportunistic moment to guide their staff to embrace change and incorporate retail and ecommerce technologies. It’s is exciting to be a leader in this transformational time,” said Schultz.

In addition, Joe Clemons joined the Advisory services team as an experienced healthcare leader who has successfully managed projects and multi-disciplinary teams across clinical, business, financial and technical operations functions with system selection, implementation and post-live support. Clemons also started his career in pharmacy management and pivoted to healthcare IT, where he led many EHR and pharmacy system implementations, served as the ICD-10 program manager for a large health system and managed Workday HRIS/ERP system implementations.

“Pivot Point Consulting invests in top notch healthcare IT leaders who bring decades of practical strategy and implementation experience to deliver value for both today’s and tomorrow’s opportunities.” – Rachel Marano, Managing Partner & Co-Founder.

About Pivot Point Consulting

Pivot Point Consulting enables healthcare organizations to realize the most value from their technology and data through their KLAS ranked advisory, implementation/optimization, managed services and talent solutions.

The company provides strategy and consulting services for providers, payers and life sciences organizations – with roughly 400 consultants serving 85+ clients across the United States. Pivot Point Consulting has earned many industry and workplace quality awards including: Top three Best in KLAS for HIT Implementation and Support for four years running (2015, 2016, 2017 and 2018), Highest Rated Vendor in KLAS Implementation Services in the Select Category (July 2017), #1 in KLAS for Epic Consulting in the Select Category (2016), #9 in Modern Healthcare’s Best Places to Work in 2016.

For more information about Pivot Point Consulting, visit http://www.pivotpointconsulting.com. Follow us on LinkedIn.

Share article on social media or email: